Literature DB >> 2614255

Evidence for high density lipoproteins as the major apolipoprotein A-IV-containing fraction in normal human serum.

L Lagrost1, P Gambert, M Boquillon, C Lallemant.   

Abstract

The distribution of human apolipoprotein A-IV was studied in sera from normolipidemic fasting subjects by high performance gel filtration on a Superose 12 HR column. The major part of apolipoprotein A-IV eluted in the range of the apolipoprotein A-I peak, and distributed mainly in the large-size high density lipoprotein subfractions. Only a small peak or a shoulder on the main fraction appeared in the elution volume of free apolipoprotein A-IV. To investigate the relation of apolipoprotein A-IV with high density lipoprotein particles, serum high density lipoproteins were precipitated by incubating human serum with anti-apolipoprotein A-I immunoglobulins. At optimal concentrations, inducing a precipitation of 90 to 95% of serum apolipoprotein A-I, about 70% of serum apolipoprotein A-IV was precipitated. It was concluded that, in fasting human serum, apolipoprotein A-IV was mainly associated with high density lipoprotein particles. This high degree of association to high density lipoproteins did not result from the known in vitro redistribution of apolipoprotein A-IV induced by lecithin: cholesterol acyltransferase activity since it was observed in sera in the presence of inhibitors of this enzyme. The comparison of gel filtration profiles of total serum and of serum fractions separated by ultracentrifugation showed that the apolipoprotein A-IV-high density lipoprotein association was a weak one, easily dissociated by the ultracentrifugation process. The existence in fasting human serum of a predominant high density lipoprotein-associated form of apolipoprotein A-IV should stimulate more studies of the general function and metabolism of this protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2614255

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins.

Authors:  S T Kunitake; M R Jarvis; R L Hamilton; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.

Authors:  R D Cohen; L W Castellani; J H Qiao; B J Van Lenten; A J Lusis; K Reue
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

3.  Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.

Authors:  D J Rader; J Schäfer; P Lohse; B Verges; M Kindt; L A Zech; A Steinmetz; H B Brewer
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

4.  Transcriptional regulation of apolipoprotein A-IV by the transcription factor CREBH.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Kyu Yeon Hur; Ann-Hwee Lee
Journal:  J Lipid Res       Date:  2014-03-05       Impact factor: 5.922

5.  Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas.

Authors:  C L Hanis; T C Douglas; D Hewett-Emmett
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132

6.  ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT.

Authors:  Adelina Duka; Panagiotis Fotakis; Dimitra Georgiadou; Andreas Kateifides; Kalliopi Tzavlaki; Leonard von Eckardstein; Efstratios Stratikos; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2012-11-06       Impact factor: 5.922

7.  Effects of elaidic acid on lipid metabolism in HepG2 cells, investigated by an integrated approach of lipidomics, transcriptomics and proteomics.

Authors:  Lone Vendel Nielsen; Toke P Krogager; Clifford Young; Carla Ferreri; Chryssostomos Chatgilialoglu; Ole Nørregaard Jensen; Jan J Enghild
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

8.  Cholesterol-secreting and statin-responsive hepatocytes from human ES and iPS cells to model hepatic involvement in cardiovascular health.

Authors:  Winfried H Krueger; Borko Tanasijevic; Vanessa Barber; Anthony Flamier; Xinsheng Gu; Jose Manautou; Theodore P Rasmussen
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.